XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.1
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments
3 Months Ended
Mar. 31, 2025
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments  
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments

4.Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments

Our marketable investment securities, restricted cash and cash equivalents, and other investments consisted of the following:

As of

March 31,

December 31,

2025

    

2024

(In thousands)

Marketable investment securities:

Current marketable investment securities:

Strategic - available-for-sale

$

51

$

51

Strategic - trading/equity

10

10

Other

225

Total current marketable investment securities

61

286

Restricted marketable investment securities (1)

53,562

23,882

Total marketable investment securities

53,623

24,168

Restricted cash and cash equivalents (1)

248,604

254,714

Other investments, net:

Equity method investments

19,919

20,440

Other investments

15,043

15,043

Total other investments, net

34,962

35,483

Total marketable investment securities, restricted cash and cash equivalents, and other investments, net

$

337,189

$

314,365

(1)Restricted marketable investment securities and restricted cash and cash equivalents are included in “Current restricted cash, cash equivalents and marketable investment securities” and “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets and discussed below.

Marketable Investment Securities

Our marketable investment securities portfolio may consist of debt and equity instruments. All equity securities are carried at fair value, with changes in fair value recognized in “Other, net” within “Other Income (Expense)” on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). All debt securities are classified as available-for-sale and are recorded at fair value.

We report the temporary unrealized gains and losses related to changes in market conditions of marketable debt securities as a separate component of “Accumulated other comprehensive income (loss)” within “Stockholder’s Equity (Deficit),” net of related deferred income tax on our Condensed Consolidated Balance Sheets. The corresponding changes in the fair value of marketable debt securities, which are determined to be company specific credit losses are recorded in “Other, net” within “Other Income (Expense)” on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). See Note 2 for further information.

Current Marketable Investment Securities Strategic

Our current strategic marketable investment securities portfolio includes and may include strategic and financial debt and/or equity investments in private and public companies that are highly speculative and have experienced and continue to experience volatility. As of March 31, 2025, this portfolio consisted of securities of a small number of issuers, and as a result the value of that portfolio depends, among other things, on the performance of those issuers. The fair value of certain of the debt and equity securities in this portfolio can be adversely impacted by, among other things, the issuers’ respective performance and ability to obtain any necessary additional financing on acceptable terms, or at all.

Current Marketable Investment Securities - Other

Our current other marketable investment securities portfolio includes investments in various debt instruments including, among others, commercial paper, corporate securities and United States treasury and/or agency securities.

Commercial paper consists mainly of unsecured short-term, promissory notes issued primarily by corporations with maturities ranging up to 365 days. Corporate securities consist of debt instruments issued by corporations with various maturities normally less than 18 months. U.S. Treasury and agency securities consist of debt instruments issued by the federal government and other government agencies.

Restricted Cash, Cash Equivalents and Marketable Investment Securities

As of March 31, 2025 and December 31, 2024, our restricted marketable investment securities, together with our restricted cash and cash equivalents, included amounts required as collateral for our letters of credit, surety bonds and trusts.

Current restricted cash, cash equivalents and marketable investment securities. As of March 31, 2025 and December 31, 2024, we had $173 million and $151 million, respectively, included in “Current restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets that primarily consists of funds received by our subsidiary, DISH DBS Issuer LLC (“DBS SubscriberCo”), from subscriber payments and certain other revenue, which are required to be restricted per the terms of the debt issued by DBS SubscriberCo. DBS SubscriberCo holds certain DISH TV subscribers and their related subscription and equipment agreements which collateralizes certain debt obligations.

Other Investments, net

We have strategic investments in certain debt and/or equity securities that are included in noncurrent “Other investments, net” on our Condensed Consolidated Balance Sheets. Our debt securities are classified as available-for-sale and are recorded at fair value. Generally, our debt investments in non-publicly traded debt instruments without a readily determinable fair value are recorded at amortized cost. Our equity investments where we have the ability to exercise significant influence over the investee are accounted for using the equity method of accounting. Certain of our equity method investments are detailed below.

NagraStar L.L.C. We own a 50% interest in NagraStar L.L.C. (“NagraStar”), a joint venture that is our primary provider of encryption and related security systems intended to assure that only authorized customers have access to our programming. The three main technologies NagraStar provides to its customers are microchips, set-top box software and uplink computer systems. NagraStar also provides end-to-end platform security testing services.

Invidi Technologies Corporation. We own a 35% interest in Invidi Technologies Corporation (“Invidi”), an entity that provides proprietary software for the addressable advertising market. Invidi contracts with multichannel video programming distributers to include its software in their respective set-top boxes and DVRs in order to deliver targeted advertisements based on a variety of demographic attributes selected by the advertisers. Invidi has also developed a cloud-based solution for internet protocol-based platforms.

We also hold investments that are not accounted for using the equity method of accounting, which are measured at fair value. Investments in equity securities without readily determinable fair values are accounted for at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer.

Our ability to realize value from our strategic investments in securities that are not publicly traded depends on, among other things, the success of the issuers’ businesses and their ability to obtain sufficient capital, on acceptable terms or at all, and to execute their business plans. Because private markets are not as liquid as public markets, there is also increased risk that we will not be able to sell these investments, or that when we desire to sell them we will not be able to obtain fair value for them.

Fair Value Measurements

Our investments measured at fair value on a recurring basis were as follows:

As of

March 31, 2025

December 31, 2024

    

Level 1

    

Level 2

    

Level 3

    

Total

    

Level 1

    

Level 2

    

Level 3

    

Total

(In thousands)

Cash and cash equivalents (including restricted):

Cash

$

405,351

$

$

$

405,351

$

468,799

$

$

$

468,799

Cash equivalents

154,447

480,541

634,988

221,083

40,907

261,990

Total

$

559,798

$

480,541

$

$

1,040,339

$

689,882

$

40,907

$

$

730,789

Debt securities (including restricted):

U.S. Treasury and agency securities

$

10,356

$

$

$

10,356

$

8,163

$

$

$

8,163

Commercial paper

17,981

17,981

Corporate securities

24,885

24,885

15,719

15,719

Other

340

51

391

225

51

276

Equity securities

10

10

10

10

Total

$

10,366

$

43,206

$

51

$

53,623

$

8,173

$

15,944

$

51

$

24,168

As of March 31, 2025, restricted and non-restricted marketable investment securities included debt securities of $32 million with contractual maturities within one year and $22 million with contractual maturities extending longer than one year through and including five years. Actual maturities may differ from contractual maturities as a result of our ability to sell these securities prior to maturity.

Gains and Losses on Sales and Changes in Carrying Amounts of Investments and Other

“Other, net” within “Other Income (Expense)” included on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) is as follows:

For the Three Months Ended 

March 31,

Other, net:

    

2025

    

2024

 

(In thousands)

Marketable and non-marketable investment securities - realized and unrealized gains (losses)

$

5

$

(870)

Sale of Assets to EchoStar - realized gains (losses) (Note 12)

128,788

Equity in earnings (losses) of affiliates

(481)

(708)

Other

(4)

132

Total

$

(480)

$

127,342